ArticleFrontiers in oncology2026

STAT3 inhibitor in oncology: a trial-based analysis of translational challenges and evolving therapeutic paradigms.

Siyuan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.